3 completed. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Andrew D. Luster, M.D.,Ph.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lung-Resident Memory Th2 Cells in Asthma Bronchoscopy/BAL, Airway Brushing - Asthma, Allergic | Not applicable | Completed | Andrew D. Luster, M.D.,Ph.D. | 37 | 2019-05-23 | 2026-09-30 |
| Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage, Phlebotomy - Asthma, Allergies | Phase 1 | Completed | Andrew D. Luster, M.D.,Ph.D. | 43 | 2013-01-01 | 2026-09-28 |
| T Cell Effector and Regulatory Mechanisms in Asthma Bronchoscopy, Segmental Allergen Challenge and Broncheoalveolar Lavage, PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging) - Asthma, Allergies | Phase 1 | Completed | Andrew D. Luster, M.D.,Ph.D. | 168 | 2012-09-01 | 2017-09-15 |
Asthma (3) · Inflammation (3) · Hypersensitivity (2) · Constriction, Pathologic (1)
Bronchoscopy (2) · Blood Specimen Collection (1) · Bronchoalveolar Lavage (1) · Fluorodeoxyglucose F18 (1) · Phlebotomy (1) · Ventilation (1)
United States (3)
Andrew D Luster, M.D., Ph.D. (2) · Andrew D Luster (1)
U19AI095261 (2), R01AI040618 (1)